TGFB1 and pulmonary fibrosis: In this study, we found that MLB treatment could efficiently inhibit pulmonary fibrosis both in a bleomycin (BLM)-induced pulmonary fibrosis mouse model and in TGF-β-stimulated human type II alveolar epithelial cell line (A549) cells and human lung fibroblast cell line (MRC-5) cells.